TABLE 1.

Patients’ clinical data are summarized in this table.

	Age (years) and Sex	PFS (months)	OS (months)	Time of diagnosis	Date of recurrence	Date of last follow-up/Death	Side	Localization	Histology
1.	52 Male	5	26	2012. 09	2013. 02	2014. 11	Left	Temporalis	Glioblastoma
2.	53 Male	4	12	2011. 02	2011. 06	2012. 02	Left	Temporo-parietalis	Glioblastoma
3.	47 Male	4	20	2010. 09	2011. 01	2012. 05	Left	Frontalis	Glioblastoma
4.	68 Male	13	20	2013. 01	2014. 02	2014. 09	Left	Temporalis	Glioblastoma
5.	54 Female	34	35	2010. 04	2013. 02	2013. 03	Left	Frontalis	Glioblastoma
6.	67 Male	5	12	2012. 02	2012. 07	2013. 02	Left	Temporalis	Glioblastoma
7.	26 Male	28	46	2010. 03	2012. 08	2014. 01	Right	Frontalis	Glioblastoma
8.	29 Male	47	64	2012. 05	2016. 04	2017. 09	Left	Fronto-parietalis	Oligodendroglioma –Gr 3
9.	34 Male	6	11	2010. 12	2011. 05	2011. 10	Left	Frontalis	Glioblastoma
10.	67 Female	37	37	2012. 06	2015. 07	2015. 07	Right	Frontalis	Oligodendroglioma –Gr 3
11.	51 Female	61	72	2011. 02	2016. 03	2017. 02	Left	Parietalis	Oligodendroglioma –Gr 3
12.	39 Male	22	47	2010. 07	2012. 05	2014. 06	Right	Parieto-occipitalis	Glioblastoma
13.	55 Male	2	4	2021. 02	2021. 04	2021. 06	Right	Temporo-parieto-occipitalis	Glioblastoma
14.	77 Female	8	10	2019. 10	2020. 06	2020. 08	Left	Temporo-parietalis	Glioblastoma
15.	68 Male	8	10	2020. 04	2021. 12	2022. 02	Left	Frontalis	Oligodendroglioma –Gr 3
16.	59 Male	2	3	2021. 10	2021. 12	2022. 02	Left	Frontalis	Glioblastoma
17.	56 Male	2	28	2019. 11	2020. 01	2022. 03	Left	Parietalis	Glioblastoma
18.	46 Female	1	2	2021. 12	2022. 01	2022. 02	Left	Parietalis	Glioblastoma
19.	36 Male	3	6	2020. 10	2021. 01	2021. 04	Left	Parietalis	Glioblastoma
20.	46 Male	4	15	2019. 11	2020. 03	2021. 02	Right	Frontalis	Glioblastoma

PFS, progression free survival; OS, overall survival.